Search - tctmd.com

Displaying 541 - 560 of 636

Sort: Relevancy | Date

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

Presenter: A. Marc Gillinov

October 23, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Presenter: Bryan Yan

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Prevail Study: Design and Current Status

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

PFM Medical: Device Description and Preclinical Results

Presenter: Alexander Javois

October 23, 2012

Presentation TCT 2012

Outcomes and Insights from the European ACP Registry

Presenter: Jai-Wun Park

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Presentation TCT 2012

LARIAT Tips and Tricks

Presenter: Steven Yakubov

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Advertisement

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

WATCHMAN Tips and Tricks

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

The New Anticoagulants: A Meaningful Step Forward?

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Prevail Study: Design and Current Status

PFM Medical: Device Description and Preclinical Results

Outcomes and Insights from the European ACP Registry

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Lifetech LAA Closure Device: Description and Preclinical Results

LARIAT Tips and Tricks

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content